Dong-mei Zhang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir.
Journal: Annals of hepatology
Published: January 25, 2023
Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.
Journal: Frontiers in microbiology
Published: March 21, 2022
Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B.
Journal: Scientific reports
Published: April 28, 2020
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment.
Journal: Journal of viral hepatitis
Published: September 20, 2019
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavir.
Journal: Journal of medical virology
Published: September 05, 2019
Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy.
Journal: Infectious diseases (London, England)
Published: February 22, 2018
Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy.
Journal: Scandinavian journal of gastroenterology
Published: September 08, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026